Clinical Trial Update: Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the effect of topical Mitomycin C 0.02% on the corneal endothelium after photorefractive keratectomy in moderate myopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Mitomycin C 0.02% (Mitomycin C)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Myopia | Phase 1 | Status: UNKNOWN